Related Experiment Videos
p53 and chemosensitivity
C G Ferreira1, C Tolis, G Giaccone
1Department of Medical Oncology, University Hospital Vrije Universiteit, Amsterdam, The Netherlands.
Background:
Although hematologic malignancies and some solid tumors such as germ cell tumors and pediatric malignancies can be cured by cytotoxic treatment, the most prevalent solid tumors are relatively resistant to these interventions. Apoptosis is involved in the cell kill of anticancer drugs and p53 is believed to be of principal importance in this process. However p53 also plays a role in cell cycle arrest and DNA repair, cellular processes that can decrease the sensitivity to chemotherapy. Therefore, p53 may play a dual role after exposure to cytotoxic treatment, activating either mechanisms that lead to apoptosis or launching processes directing to DNA repair and survival of the cell.
Design:
In this article, we review in details the p53 functions involved in the mediation of chemosensitivity. The preclinical and clinical data published in the recent years about the relation between p53 and chemosensitivity are discussed and the potential pitfalls associated to most of these studies, and that may account for the contradictory results produced so far are also mentioned.
Insights
The tumor suppressor protein p53 has a dual role in chemotherapy response. It can promote cancer cell death (apoptosis) or DNA repair and survival, impacting treatment effectiveness.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Most prevalent solid tumors exhibit resistance to cytotoxic chemotherapy.
- The tumor suppressor protein p53 is crucial for apoptosis, a key mechanism in chemotherapy-induced cancer cell death.
- p53 also mediates cell cycle arrest and DNA repair, potentially reducing chemotherapy sensitivity.
Purpose of the Study:
- To review the multifaceted roles of p53 in mediating chemosensitivity.
- To discuss preclinical and clinical data linking p53 status to chemotherapy response.
- To identify potential limitations in studies investigating p53 and chemosensitivity.
Main Methods:
- Comprehensive review of peer-reviewed literature.
- Analysis of preclinical data on p53 and chemosensitivity.
- Discussion of clinical findings regarding p53 and treatment outcomes.
Main Results:
- p53 exhibits a dual function: promoting apoptosis or facilitating DNA repair and cell survival.
- Contradictory results in existing studies may stem from methodological limitations.
- Understanding p53's complex role is vital for predicting and improving chemotherapy efficacy.
Conclusions:
- The p53 protein's role in chemosensitivity is complex and context-dependent.
- Further research is needed to reconcile conflicting data and elucidate p53's precise impact on treatment response.
- Targeting p53 pathways may offer novel strategies to enhance cancer therapy outcomes.